Analysis of differential microbiome and classification prediction model between case and control groups. by Chuan Zhang (187157)

“…<p><b>(A)</b> Linear discriminant analysis [LDA; (log10)>2] and (B) effect size (LEfSe) analysis revealed significant differences (P < 0.01) in the microbiota of the case (orange, negative score) and control groups (blue, positive score) groups. …”

Acoustic startle at 6 dpf. by Morgan Barnes (7876373)

“…There are significant decreases in LLC responses in the 24+ (p < 0.0001) and 48+ (p ≤ 0.0001) fish. …”

The <i>ENT2</i> knockout effects on CRC proliferation and survival. by Safaa M. Naes (22075434)

“…Plating Efficiency (PE) was calculated as the ratio of the number of colonies to the number of cells seeded. PE decreased significantly in both HKO1 and HKO2. No significant difference occurred between NTC and DKO cells. …”

Vacancy Engineering Strategy Releases the Electrocatalytic Oxygen Evolution Reaction Activity of High-Entropy Oxides by Boxiong Shen (1557838)

“…The sluggish kinetics of oxygen evolution reaction (OER) poses a great challenge to the industrial promotion of electrocatalytic water splitting and zinc-air battery. …”

Vacancy Engineering Strategy Releases the Electrocatalytic Oxygen Evolution Reaction Activity of High-Entropy Oxides by Boxiong Shen (1557838)

“…The sluggish kinetics of oxygen evolution reaction (OER) poses a great challenge to the industrial promotion of electrocatalytic water splitting and zinc-air battery. …”

Search strategy. by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Fig 1 - by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

GMT by age cohort for PWH and PWoH. by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Fig 4 - by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Difference in GMT for HPV16 and HPV18 in PWH. by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Fig 3 - by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Summary of characteristics of studies reviewed. by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Cumulative meta-analysis. by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Summary of immunogenicity information. by Alvine M. Akumbom (20460907)

“…Risk factors for incident or persistent infections in PWH included: failure to seroconvert after vaccination, baseline CD4+ T-cell count <500 cells/mm3, early age of sexual debut, HIV viral load ≥ 400 copies/mL. There was a trend towards decreased HPV vaccine efficacy in studies that included enrollees with a history of AIDS or AIDS-defining illness.Applying existing evidence of HPV vaccine efficacy on meaningful clinical outcomes in PWH is questionable. …”

Raw data for Figs 1, 2, 3, 4 and S2. by Areej A. Alfaifi (20422411)

“…Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin and amylase genes. …”

Fig 5 - by Joon Young Park (15256702)

“…Among the three RpoD binding sites upstream of <i>cyoABCDE</i>, only the binding intensity at the site corresponding to the transcription start site (TSS) significantly decreases. Additionally, a significant reduction in RpoD binding is also observed for <i>atpIBEFHAGDC</i>. …”

Raw data. by Mohamed Condé (22622306)

“…Increased use of opiates in the Emergency Department, elevated total leucocyte count, breath rate, and decreased red blood cell count were not significantly associated with ACS occurrence (p > 0.05). …”

Risk factors for ACS (multivariate analysis). by Mohamed Condé (22622306)

“…Increased use of opiates in the Emergency Department, elevated total leucocyte count, breath rate, and decreased red blood cell count were not significantly associated with ACS occurrence (p > 0.05). …”

Raw data. by Mohamed Condé (22622306)

“…Increased use of opiates in the Emergency Department, elevated total leucocyte count, breath rate, and decreased red blood cell count were not significantly associated with ACS occurrence (p > 0.05). …”

Characteristics of the 280 VOCs at inclusion. by Mohamed Condé (22622306)

“…Increased use of opiates in the Emergency Department, elevated total leucocyte count, breath rate, and decreased red blood cell count were not significantly associated with ACS occurrence (p > 0.05). …”